[Comparison of the effectiveness and tolerance of a new beta-2 stimulant (broxaterol) vs. salbutamol in patients with chronic obstructive bronchopneumopathy].
D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000420:Albuterol / Q000627:therapeutic use*; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use*; D008173:Lung Diseases, Obstructive / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D010080:Oxazoles / Q000627:therapeutic use*; D014797:Vital Capacity
D000318:Adrenergic beta-Agonists; D007555:Isoxazoles; D010080:Oxazoles; D000420:Albuterol; C045916:broxaterol
Comparazione dell'efficacia e della tollerabilità di un nuovo beta-2 stimolante (broxaterolo) vs. salbutamolo in pazienti affetti da broncopneumopatia cronica ostruttiva.